An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

BACKGROUND: Since the COVID-19 outbreak an unprecedented challenge for healthcare systems around the world has been placed. In Cuba, the first case of COVID-19 was reported on March 11. Elderly with multiple comorbidities have been the most risky population. Although most patients present a mild to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Immun Ageing
Autors principals: Saavedra, Danay, Añé-Kourí, Ana Laura, Sánchez, Naivy, Filgueira, Lázaro Manuel, Betancourt, Julio, Herrera, Carlos, Manso, Leniel, Chávez, Elibet, Caballero, Armando, Hidalgo, Carlos, Lorenzo, Geydi, Cepeda, Meylan, Valenzuela, Carmen, Ramos, Mayra, León, Kalet, Mazorra, Zaima, Crombet, Tania
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7666403/
https://ncbi.nlm.nih.gov/pubmed/33292350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12979-020-00207-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars